Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Cirrhosis Portal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05071716
What this trial is testing

Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis

Who this might be right for
Hepatic Encephalopathy
Bausch Health Americas, Inc. 524
Testing effectiveness (Phase 2)Active Not RecruitingNCT06256432
What this trial is testing

Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome

Who this might be right for
Hepatorenal SyndromeLiver CirrhosisAcute Kidney Injury+1 more
Noorik Biopharmaceuticals AG 54
Not applicableUnknownNCT01341132
What this trial is testing

Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents

Who this might be right for
Hepatocellular Carcinoma
San Francisco Veterans Affairs Medical Center 75
Post-approval studies (Phase 4)UnknownNCT01282398
What this trial is testing

Study About Simvastatin in Portal Hypertension in Compensated Cirrhosis

Who this might be right for
Portal Hypertension.Liver Cirrhosis
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 80
Not applicableStudy completedNCT03427164
What this trial is testing

Ultrasound Elastography Assessment of Spleen and Liver Stiffness Before and After Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedure

Who this might be right for
Portal Hypertension
University of Kansas Medical Center 30
Not applicableUnknownNCT05163132
What this trial is testing

Shear-wave Elastography Diffuse Liver Disease

Who this might be right for
Chronic HepaticChronic Liver Disease and Cirrhosis
Assiut University 80
Testing effectiveness (Phase 2)Study completedNCT01640964
What this trial is testing

An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension

Who this might be right for
Compensated Cirrhosis and Portal Hypertension
Novartis Pharmaceuticals 47
Testing effectiveness (Phase 2)Study completedNCT01349335
What this trial is testing

Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites

Who this might be right for
AscitesHepatic Cirrhosis
Otsuka Beijing Research Institute 180
Not applicableWithdrawnNCT01331785
What this trial is testing

Mechanism and the Effect of Midodrine on Portal Pressures in Patients With Cirrhosis

Who this might be right for
CirrhosisEnd Stage Liver DiseaseAscites+1 more
The Cleveland Clinic
Not applicableStudy completedNCT05154643
What this trial is testing

T1rho Imaging of Liver in Presence of Iron

Who this might be right for
Liver Fibrosis
Chinese University of Hong Kong 50
Not applicableStudy completedNCT01774617
What this trial is testing

Comparative Analysis of Different Tests to Evaluate Prognosis of Patients on Liver Transplant Waiting List

Who this might be right for
CirrhosisLiver FailurePortal Hypertension
Guilherme Rezende 80
Testing effectiveness (Phase 2)Study completedNCT06750276
What this trial is testing

Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.

Who this might be right for
Liver FibrosisHepatic Cirrhosis
AstraZeneca 40
Post-approval studies (Phase 4)UnknownNCT05473806
What this trial is testing

Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes

Who this might be right for
Hepatitis B, ChronicFibrosis, LiverDiabetes Mellitus, Type 2
Seung Up Kim 28
Post-approval studies (Phase 4)Ended earlyNCT00661349
What this trial is testing

Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV Patients

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 9
Early research (Phase 1)Study completedNCT06888115
What this trial is testing

The Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury

Who this might be right for
Primary Biliary Cholangitis
Cascade Pharmaceuticals, Inc 24
Testing effectiveness (Phase 2)Ended earlyNCT06987968
What this trial is testing

See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyAcute on Chronic Liver Failure (ACLF)Decompensated Cirrhosis
Genfit 3
Not applicableStudy completedNCT02979340
What this trial is testing

MRI to Characterize and Predict CF Liver Disease in PUSH Cohort

Who this might be right for
Cystic Fibrosis Liver DiseasePancreatic Insufficiency
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 115
Early research (Phase 1)WithdrawnNCT04055389
What this trial is testing

Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosis

Who this might be right for
Portal Vein ThrombosisCirrhosis, Liver
Jonathan Stine
Testing effectiveness (Phase 2)Ended earlyNCT05516498
What this trial is testing

Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)

Who this might be right for
Liver Cirrhosis
AstraZeneca 205
Not applicableLooking for participantsNCT06908798
What this trial is testing

Fecal Calprotectin for Prediction of Esophageal Varices in Cirrhotic Patients

Who this might be right for
Esophageal Varices
Tanta University 156
Next Page